Status:
UNKNOWN
Topical Bromfenac for Intraoperative Miosis and Pain Reduction
Lead Sponsor:
Hospital de La Luz
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the effect of bromfenac ophthalmic solution 0.09% for reduction of intraoperative miosis and pain in patient who have undergone femtosecond laser-assisted cataract surgery.
Detailed Description
This prospective cross-sectional randomized clinical study included 60 patients with senile cataract in the absence of significant ocular comorbidity. The patients received 0.09% bromfenac ophthalmic ...
Eligibility Criteria
Inclusion
- Male and female
- Subjects 18 years or older
- Patients scheduled for unilateral femtosecond laser-assisted cataract surgery cataract surgery with posterior chamber (PC) IOL implantation.
Exclusion
- Presence of corneal abnormalities
- History of intraocular surgery
- History of ocular or systematic diseases (glaucoma, diabetes, uveitis
- Regular, systemic use of steroid or NSAIDs during the previous 3 months
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03831984
Start Date
March 1 2018
End Date
March 30 2019
Last Update
February 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Camila Aguilar Sierra
Mexico City, Mexico, 06030